• In the present study the alternative splicing of several nAC

  2023-03-11

  

  In the present study, the alternative splicing of several nAChR subunits was identified in the oriental migratory locust (Locusta migratoria manilensis Meyen), a serious worldwide pest to agricultural production and also a model insect species [5]. Several α subunits were tried to co-express with ra

• br Materials and methods br Results br Discussion The succes

  2023-03-11

  

  Materials and methods Results Discussion The success of CAR-T cell therapy is based on two major facts: one is that cancer cells express tumor-associated antigens (TAAs) on their surface that can be detected by the human immune system; the other is that the CAR molecules target these TAAs o

• At the outset of targeting

  2023-03-11

  

  At the outset of targeting the two Gln756 side-chain rotamers, it was unclear which rotational isomer would lead to more potent ASK1 inhibitors. While such a preference might have been anticipated, the cohort of ASK1 inhibitors in Table 3 did not provide any guidance regarding which of the Gln756 am

• Sixth significant progress has been made during the last few

  2023-03-08

  

  Sixth, significant progress has been made during the last few years regarding the molecular mechanisms underlying the activation of AMPK and this should aid to develop more potent and specific compounds. Information from crystallographic structures combined with computer-based drug design hold promi

• Recently two distinct small molecule inhibitors of PHGDH

  2023-03-08

  

  Recently, two distinct small-molecule inhibitors of PHGDH were identified using high-throughput screens, both of which inhibit de novo serine biosynthesis and show selective toxicity to cancer DCG IV synthesis with high SSP flux [50,51]. The inhibitor NCT-503, which has an IC50 of 2.5μM, reduces th

• br Regulation of AHR Activity AHR activity is

  2023-03-08

  

  Regulation of AHR Activity AHR activity is regulated in various ways. First, AHR protein levels are controlled via ubiquitin-mediated proteosomal degradation: Ligand binding induces AHR ubiquitination and subsequent degradation by the proteasome [5]. AIP, a component of the AHR chaperone complex,

• br Effective therapeutic window of AR

  2023-03-08

  

  Effective therapeutic window of AR actions on ROP Retinal vasculature undergoes critical developmental changes postnatally: from P7 onward the superficial A 804598 start sprouting vertically in retina to form first the deep then the intermediated vascular plexus in the retina of C57BL/6 mice (Sm

• Our initial approach to identify hits was

  2023-03-08

  

  Our initial approach to identify hits was two-pronged and included a high-throughput screening (HTS) campaign of the OSI KY 02111 receptor library as well as a virtual screening (VS) campaign, utilizing a publically available crystal structure of ACK1 (PDB code: ). A tolerance for protein flexibili

• The biological characteristics of cancer invasion and

  2023-03-08

  

  The biological characteristics of cancer invasion and metastasis are mainly attributed to the poor prognosis in cancer. It has been reported that overexpression of Ack1 promoted the migratory and invasive properties of breast cancer azd9291 by sustaining expression of epidermal growth factor. In co

• Molecular docking simulations were carried out for ligands

  2023-03-07

  

  Molecular docking simulations were carried out for ligands – in the ACE crystal structure (1O86) and DPP4 crystal structure (2G5P). Comparison of the binding mode of – () with enalaprilat (a) in ACE shows that the phenethyl group (–, enalaprilat) occupies the S1 pocket and the adjacent carboxylic L-

• An AXL decoy receptor with enhanced

  2023-03-07

  

  An AXL decoy receptor with enhanced GAS6-binding properties, MYD1, was engineered as a therapeutic tool to disrupt GAS6/AXL signaling in vivo (Kariolis et al., 2014). MYD1 was shown to block metastasis of human ovarian cancer FITC, Fluorescein isothiocyanate mg and a murine breast cancer cell line

• An AXL decoy receptor with enhanced

  2023-03-07

  

  An AXL decoy receptor with enhanced GAS6-binding properties, MYD1, was engineered as a therapeutic tool to disrupt GAS6/AXL signaling in vivo (Kariolis et al., 2014). MYD1 was shown to block metastasis of human ovarian cancer FITC, Fluorescein isothiocyanate mg and a murine breast cancer cell line

• An AXL decoy receptor with enhanced

  2023-03-07

  

  An AXL decoy receptor with enhanced GAS6-binding properties, MYD1, was engineered as a therapeutic tool to disrupt GAS6/AXL signaling in vivo (Kariolis et al., 2014). MYD1 was shown to block metastasis of human ovarian cancer FITC, Fluorescein isothiocyanate mg and a murine breast cancer cell line

• br ROS in AiP and regeneration Tissue wounding and inflammat

  2023-03-06

  

  ROS in AiP and regeneration Tissue wounding and inflammation are associated with production of ROS, and recent studies show that generation of ROS, especially during the initial stages of wounding and regeneration are essential for an efficient wound healing response. ROS, in particular H2O2 func

• MLN9708 Recently AFF was used to

  2023-03-06

  

  Recently, AFF was used to convert an FN3-based binder specific to the Src homology 2 (SH2) domain of cAbl kinase into an allosterically regulated, intermolecular fluorescent switch (Figure 2D). Binding to cAbl kinase co-operatively stabilized the assembly of the FN3-based binder from two partial fra

8051 records 355/537 page Previous Next First page 上5页 351352353354355 下5页 Last page